Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Dementia Alzheimer's Disease

Caffeine and Alzheimer’s disease: Moderate intake may slow cognitive decline

by Eric W. Dolan
May 15, 2025
in Alzheimer's Disease
[Adobe Stock]

[Adobe Stock]

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

A new scientific review published in Cureus suggests that moderate caffeine consumption might help protect against the progression of Alzheimer’s disease, especially in individuals with mild cognitive impairment. Although the evidence is not entirely consistent, the findings point toward a possible dose-dependent relationship, with higher caffeine levels associated with slower cognitive decline.

Alzheimer’s disease is the most common form of dementia, affecting millions of people worldwide. As life expectancy increases, the number of individuals living with Alzheimer’s is expected to rise significantly, tripling by 2050. This has sparked a global effort to identify factors that could slow or prevent the disease’s progression. Since current treatments offer only limited relief, researchers are increasingly exploring lifestyle factors—such as diet, exercise, and sleep—for their potential protective effects. Caffeine, found in coffee, tea, and other beverages, is one such factor under investigation.

Caffeine is one of the most widely consumed substances in the world. It stimulates the brain, increases alertness, and improves mood. But scientists have also been exploring whether its effects go deeper—perhaps even helping to protect the brain against neurodegenerative diseases like Alzheimer’s. Animal studies have shown that caffeine can reduce the buildup of harmful proteins in the brain. Human research has produced mixed results, but some studies have reported that regular coffee drinkers tend to have lower rates of cognitive decline.

To better understand the potential link between caffeine intake and Alzheimer’s progression, a team of researchers from institutions in Pakistan, the United Kingdom, and the United States conducted a systematic review. They examined studies from major scientific databases to identify those that looked at how caffeine consumption affected the risk of developing Alzheimer’s or the progression from mild cognitive impairment to full-blown dementia.

The review included four studies that met strict inclusion criteria. One of the most compelling pieces of evidence came from a study that measured caffeine levels in the blood of people with mild cognitive impairment. Those with higher plasma caffeine levels—above 1200 nanograms per milliliter—did not go on to develop dementia during the study period. In contrast, those with lower levels had a significantly higher risk of progressing to Alzheimer’s.

Another study from the BALTAZAR cohort, a large European sample, found that individuals who consumed less than 216 milligrams of caffeine per day—roughly two cups of coffee—had more memory problems and worse biological markers associated with Alzheimer’s. This supports the idea that a threshold amount of caffeine may be needed to see protective effects.

A genetic study using data from the UK Biobank added more nuance to the picture. Researchers used a method called Mendelian randomization, which looks at genetic variants associated with naturally higher caffeine levels in the blood. They found a modest protective effect, but the result did not reach statistical significance. Still, it suggested that the connection between caffeine and brain health could be partly influenced by how each person’s body processes caffeine.

Another long-term study from Portugal compared people with Alzheimer’s to healthy individuals. Over the 20 years leading up to diagnosis, those who developed Alzheimer’s had consumed less caffeine than those who remained cognitively healthy. After accounting for other health conditions, this pattern remained.

Overall, the review suggests that moderate caffeine intake—generally over 200 milligrams per day—may offer some protection against Alzheimer’s disease. This protective effect seems to be strongest in people with mild cognitive impairment, a condition that often precedes Alzheimer’s but doesn’t yet cause major disruptions in daily life. Caffeine may help delay or prevent the transition from this early stage to full dementia.

The researchers also examined potential biological explanations for the effect. Caffeine blocks adenosine receptors in the brain, which can reduce inflammation and support better communication between brain cells. It may also help limit the accumulation of amyloid-beta, a protein that forms plaques in the brains of people with Alzheimer’s. Other studies have shown that caffeine boosts levels of brain-derived neurotrophic factor, a molecule that supports learning and memory by strengthening connections between neurons.

The review highlights several factors that may influence the relationship between caffeine and Alzheimer’s. Genetics play a role, especially in how the body breaks down caffeine. For example, people with certain versions of the CYP1A2 gene metabolize caffeine more slowly, which could affect how long it stays active in the body. Timing also matters. People who have consumed caffeine regularly over many years, particularly during midlife, seem to benefit more than those who start later in life.

Although these findings are encouraging, the researchers caution that the evidence is still incomplete. The four studies included in the review varied widely in design, participant populations, and methods of measuring caffeine intake. Some relied on self-reported dietary surveys, while others used blood tests. These differences make it hard to draw firm conclusions or recommend specific intake levels for everyone.

Another limitation is that most of the studies were observational. They can show associations, but they can’t prove that caffeine directly causes a reduction in Alzheimer’s risk. It’s possible that people who drink more coffee also engage in other healthy behaviors that contribute to better brain health, such as regular physical activity or a healthy diet.

The researchers call for more well-designed clinical trials that can test how different amounts of caffeine affect brain health over time. They also suggest studying different sources of caffeine—like coffee, tea, or chocolate—to determine whether the benefits come from caffeine itself or from other compounds found in these foods and drinks.

The study, “Association Between Caffeine Intake and Alzheimer’s Disease Progression: A Systematic Review,” was authored by Zarbakhta Ashfaq, Zainab Younas, Eemaz Nathaniel, Abdur Rehman, Arzoo Siddiqi, Naveed Rasool, and Maaz Amir.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests
Alzheimer's Disease

Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests

June 14, 2025

Spending less time in slow wave and REM sleep may accelerate brain atrophy in regions affected early in Alzheimer’s disease, according to new research. The findings support sleep quality as a potential factor in preserving brain health.

Read moreDetails
Neuroscience discoveries: 5 new studies offer unexpected insights into the brain
Alzheimer's Disease

Common sleep aid blocks brain inflammation and tau buildup in Alzheimer’s model

June 13, 2025

Scientists have found that lemborexant not only increased restorative sleep in male mice but also reduced levels of toxic tau and brain inflammation. The findings suggest that targeting the brain’s orexin system may help slow Alzheimer’s progression.

Read moreDetails
Older adults adhering to Mediterranean diet have 11% lower odds of developing dementia, study finds
Alzheimer's Disease

Mediterranean diet appears to weaken the depression–Alzheimer’s connection

June 7, 2025

A new study suggests that the Mediterranean diet may reduce the biological impact of depression on the brain. In older men, depressive symptoms were linked to higher Alzheimer’s biomarkers—except in those with strong adherence to a Mediterranean-style diet.

Read moreDetails
Beta blockers: how these common heart medications may reduce the risk of violence
Alzheimer's Disease

Long-term SSRI use linked to reduced Alzheimer’s pathology but mixed effects on cognition

May 29, 2025

A new study suggests long-term SSRI use may reduce markers of Alzheimer’s disease and restore brain function in affected regions, but the impact on cognitive performance remains mixed depending on how it’s measured.

Read moreDetails
Cannabidiol shows promise for treating Alzheimer’s in mice by targeting brain hyperactivity
Alzheimer's Disease

Cannabidiol shows promise for treating Alzheimer’s in mice by targeting brain hyperactivity

May 26, 2025

In a study using an Alzheimer’s disease mouse model, researchers found that cannabidiol reduced memory loss and brain abnormalities. The compound worked by enhancing the function of glycine receptors, which help regulate neuronal activity in the brain's memory center.

Read moreDetails
A common childhood virus could be silently fueling Alzheimer’s disease in old age
Alzheimer's Disease

A common childhood virus could be silently fueling Alzheimer’s disease in old age

May 25, 2025

A virus best known for causing cold sores may dramatically increase the risk of Alzheimer’s in people with a specific gene variant. New evidence suggests herpes reactivation in the brain may trigger the destructive changes seen in the disease.

Read moreDetails
Scientists find 16 new Alzheimer’s-linked genes using multi-ancestry genome data
Alzheimer's Disease

Scientists find 16 new Alzheimer’s-linked genes using multi-ancestry genome data

May 23, 2025

A groundbreaking genome-wide analysis has revealed new genetic regions associated with Alzheimer’s disease—many missed in past studies focused on European populations. The findings point to underexplored biological pathways and highlight the value of studying diverse ancestry groups.

Read moreDetails
New eye test may detect Alzheimer’s disease years before symptoms emerge, study suggests
Alzheimer's Disease

New eye test may detect Alzheimer’s disease years before symptoms emerge, study suggests

May 18, 2025

A low-cost, noninvasive eye scan could help detect Alzheimer’s disease earlier than current methods. The technique may expand access to early diagnosis, especially in underserved communities, and provide a valuable tool for intervention before irreversible brain damage occurs.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Frequent pornography use linked to altered brain connectivity and impaired cognitive performance

Childhood trauma linked to changes in brain structure and connectivity, study finds

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

COVID-19 coverage linked to rise in anti-Asian sentiment, especially among Trump supporters

Some dark personality traits may help buffer against depression, new psychology research suggests

Dementia risk begins in childhood, not old age, scientists warn

Millennials are abandoning organized religion. A new study provides insight into why

Sleep regularity might be protective of adolescents’ mental health, study suggests

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy